Eton Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 53.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing vari...